Clinical Trial Update: NESP Pediatric Study [Phase 3]

View source ↗

Summary

Amgen reports completion of the Phase 3 pediatric trial of NESP for patients with chronic kidney disease including pre-dialysis and end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• NESP

Snippet

Sponsor: Amgen | Conditions: Pre-dialysis, End Stage Renal Disease | Phase 3 | Status: COMPLETED